Detalles de la búsqueda
1.
Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity.
J Nanobiotechnology
; 20(1): 436, 2022 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195911
2.
Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules.
Int J Mol Sci
; 22(19)2021 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638867
3.
Design, Synthesis, and Therapeutic Evaluation of Poly(acrylic acid)-tetraDOCA Conjugate as a Bile Acid Transporter Inhibitor.
Bioconjug Chem
; 26(8): 1597-605, 2015 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26086474
4.
Dual mechanistic TRAIL nanocarrier based on PEGylated heparin taurocholate and protamine which exerts both pro-apoptotic and anti-angiogenic effects.
J Control Release
; 336: 181-191, 2021 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34144107
5.
Self-assembled nanocomplex of PEGylated protamine and heparin-suramin conjugate for accumulation at the tumor site.
Int J Pharm
; 535(1-2): 38-46, 2018 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29097141
6.
Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivo.
Biomaterials
; 148: 1-15, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28957709
7.
Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy.
J Control Release
; 197: 180-9, 2015 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25445701
8.
Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex.
Biomaterials
; 33(17): 4424-30, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22425551
Resultados
1 -
8
de 8
1
Próxima >
>>